11月3日，益丰药房盘中上涨2.09%，截至10:29，报24.93元/股，成交7192.64万元，换手率0.24%，总市 值302.26亿元。 资金流向方面，主力资金净流入336.32万元，特大单买入122.48万元，占比1.70%，卖出0.00元，占比 0.00%；大单买入1174.80万元，占比16.33%，卖出960.95万元，占比13.36%。 分红方面，益丰药房A股上市后累计派现28.52亿元。近三年，累计派现19.46亿元。 机构持仓方面，截止2025年9月30日，益丰药房十大流通股东中，香港中央结算有限公司位居第二大流 通股东，持股1.99亿股，相比上期减少3819.35万股。南方中证500ETF（510500）位居第七大流通股 东，持股881.27万股，相比上期减少17.31万股。交银新成长混合（519736）位居第八大流通股东，持股 845.41万股，为新进股东。中欧医疗健康混合A（003095）退出十大流通股东之列。 责任编辑：小浪快报 益丰药房今年以来股价涨6.40%，近5个交易日跌1.62%，近20日涨0.44%，近60日涨4.27%。 资料显示，益丰大药房连锁股份有限公司位于湖南省 ...

Core Insights - Yifeng Pharmacy's stock price remained unchanged on October 22, with a trading volume of 129 million yuan, indicating stable market activity [1] - The company reported a financing net purchase of 980,700 yuan on the same day, reflecting a low financing balance compared to historical levels [1] - For the first half of 2025, Yifeng Pharmacy achieved a revenue of 11.722 billion yuan, a slight decrease of 0.35% year-on-year, while net profit increased by 10.32% to 880 million yuan [2] Financing and Margin Trading - On October 22, Yifeng Pharmacy had a financing buy amount of 9.0041 million yuan and a financing repayment of 8.0234 million yuan, resulting in a net financing purchase of 980,700 yuan [1] - The total financing and margin trading balance as of October 22 was 98.1041 million yuan, with the financing balance at 93.2032 million yuan, representing 0.31% of the circulating market value [1] - The company’s financing balance is currently below the 40th percentile of the past year, indicating a low level of leverage [1] Shareholder and Dividend Information - As of June 30, the number of shareholders increased by 7.70% to 21,600, while the average circulating shares per person decreased by 7.15% to 56,081 shares [2] - Since its A-share listing, Yifeng Pharmacy has distributed a total of 2.852 billion yuan in dividends, with 1.946 billion yuan distributed in the last three years [3] - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 237 million shares, a decrease of 35.3896 million shares from the previous period [3]

Core Viewpoint - Yifeng Pharmacy's stock price has shown a slight increase of 2.94% year-to-date, but has experienced a decline in recent trading days, indicating potential volatility in the market [1][2]. Financial Performance - As of June 30, Yifeng Pharmacy reported a revenue of 11.722 billion yuan for the first half of 2025, a year-on-year decrease of 0.35%, while the net profit attributable to shareholders was 880 million yuan, reflecting a year-on-year growth of 10.32% [2]. - Cumulative cash dividends since the company's A-share listing amount to 2.852 billion yuan, with 1.946 billion yuan distributed over the past three years [3]. Shareholder Information - The number of shareholders increased by 7.70% to 21,600 as of June 30, 2025, while the average circulating shares per person decreased by 7.15% to 56,081 shares [2]. - Major shareholders include Hong Kong Central Clearing Limited, holding 237 million shares, a decrease of approximately 35.39 million shares from the previous period [3]. Market Activity - On October 9, Yifeng Pharmacy's stock price fell by 2.15% to 24.12 yuan per share, with a trading volume of 34.5745 million yuan and a turnover rate of 0.12% [1]. - The stock has seen a net inflow of 61,400 yuan from main funds, with large orders accounting for 7.94% of purchases and 7.76% of sales [1].

Core Viewpoint - Yifeng Pharmacy's stock has experienced fluctuations, with a recent decline of 2.02% and a year-to-date increase of 5.46%, indicating mixed market sentiment towards the company [1][2]. Financial Performance - For the first half of 2025, Yifeng Pharmacy reported a revenue of 11.722 billion yuan, a slight decrease of 0.35% year-on-year, while the net profit attributable to shareholders was 880 million yuan, reflecting a growth of 10.32% [2]. - Cumulatively, since its A-share listing, Yifeng Pharmacy has distributed a total of 2.852 billion yuan in dividends, with 1.946 billion yuan distributed over the past three years [3]. Shareholder Structure - As of June 30, 2025, the number of shareholders increased by 7.70% to 21,600, while the average circulating shares per person decreased by 7.15% to 56,081 shares [2]. - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 237 million shares, which is a decrease of approximately 35.39 million shares from the previous period [3]. Market Activity - On September 22, Yifeng Pharmacy's stock price was 24.71 yuan per share, with a trading volume of 60.51 million yuan and a turnover rate of 0.20% [1]. - The stock has seen a net outflow of 3.6248 million yuan in principal funds, with large orders accounting for 11.09% of purchases and 17.08% of sales [1].